Impaired Skeletal Muscle Perfusion in Obese Zucker Rats
Overview
Authors
Affiliations
Skeletal muscle arterioles from obese Zucker rats (OZR) exhibit oxidant stress-based alterations in reactivity, enhanced alpha-adrenergic constriction, and reduced distensibility vs. microvessels of lean Zucker rats (LZR). The present study determined the impact of these alterations for perfusion and performance of in situ skeletal muscle during periods of elevated metabolic demand. During bouts of isometric tetanic contractions, fatigue of in situ gastrocnemius muscle of OZR was increased vs. LZR; this was associated with impaired active hyperemia. In OZR, vasoactive responses of skeletal muscle arterioles from the contralateral gracilis muscle were impaired, due in part to elevated oxidant tone; reactivity was improved after treatment with polyethylene glycol-superoxide dismutase (PEGSOD). Arterioles of OZR also exhibited increased alpha-adrenergic sensitivity, which was abolished by treatment with phentolamine (10-5 M). Intravenous infusion of phentolamine (10 mg/kg) or PEG-SOD (2,000 U/kg) in OZR altered neither fatigue rates nor active hyperemia from untreated levels; however, combined infusion improved performance and hyperemia, although not to levels in LZR. Microvessel density in the contralateral gastrocnemius muscle, determined via histological analyses, was reduced by approximately 25% in OZR vs. LZR, while individual arterioles from the contralateral gracilis muscle demonstrated reduced distensibility. These data suggest that altered arteriolar reactivity contributes to reduced muscle performance and active hyperemia in OZR. Further, despite pharmacological improvements in arteriolar reactivity, reduced skeletal muscle microvessel density and arteriolar distensibility also contribute substantially to reduced active hyperemia and potentially to impaired muscle performance.
Halvorson B, Menon N, Goldman D, Frisbee S, Goodwill A, Butcher J Am J Physiol Heart Circ Physiol. 2022; 323(3):H475-H489.
PMID: 35904886 PMC: 9448278. DOI: 10.1152/ajpheart.00264.2022.
Dobrocsyova V, Slamkova M, Krskova K, Balazova L, Suski M, Olszanecki R Oxid Med Cell Longev. 2020; 2020:6372935.
PMID: 32089774 PMC: 7008284. DOI: 10.1155/2020/6372935.
Lewis M, Kasper J, Bazil J, Frisbee J, Wiseman R Int J Mol Sci. 2019; 20(21).
PMID: 31652915 PMC: 6862501. DOI: 10.3390/ijms20215271.
Lory V, Balazova L, Krskova K, Horvathova L, Olszanecki R, Suski M J Physiol Biochem. 2019; 75(3):351-365.
PMID: 31197649 DOI: 10.1007/s13105-019-00689-1.
Green S, OConnor E, Kiely C, OShea D, Egana M Physiol Rep. 2018; 6(9):e13705.
PMID: 29756296 PMC: 5949330. DOI: 10.14814/phy2.13705.